These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28888073)

  • 1. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
    Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Chen Y; Chen K; Chao MV; Counts SE; Mufson EJ
    Neurobiol Dis; 2019 Dec; 132():104540. PubMed ID: 31349032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.
    Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ
    Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.
    Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S
    Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.
    Ginsberg SD; Alldred MJ; Che S
    Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.
    He B; Perez SE; Lee SH; Ginsberg SD; Malek-Ahmadi M; Mufson EJ
    J Comp Neurol; 2020 Nov; 528(16):2748-2766. PubMed ID: 32323319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
    Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
    J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
    Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
    Alldred MJ; Pidikiti H; Ibrahim KW; Lee SH; Heguy A; Hoffman GE; Mufson EJ; Stutzmann GE; Ginsberg SD
    J Alzheimers Dis; 2024; 100(s1):S341-S362. PubMed ID: 39031371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease.
    Mufson EJ; He B; Nadeem M; Perez SE; Counts SE; Leurgans S; Fritz J; Lah J; Ginsberg SD; Wuu J; Scheff SW
    J Neuropathol Exp Neurol; 2012 Nov; 71(11):1018-29. PubMed ID: 23095849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    J Alzheimers Dis; 2018; 62(1):115-131. PubMed ID: 29439356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.
    Ikonomovic MD; Mufson EJ; Wuu J; Cochran EJ; Bennett DA; DeKosky ST
    J Alzheimers Dis; 2003 Feb; 5(1):39-48. PubMed ID: 12590165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
    Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
    Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal plasticity during the progression of Alzheimer's disease.
    Mufson EJ; Mahady L; Waters D; Counts SE; Perez SE; DeKosky ST; Ginsberg SD; Ikonomovic MD; Scheff SW; Binder LI
    Neuroscience; 2015 Nov; 309():51-67. PubMed ID: 25772787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.
    Perez SE; He B; Nadeem M; Wuu J; Scheff SW; Abrahamson EE; Ikonomovic MD; Mufson EJ
    Biol Psychiatry; 2015 Apr; 77(8):693-703. PubMed ID: 24529280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.
    Adams SL; Benayoun L; Tilton K; Chavez OR; Himali JJ; Blusztajn JK; Seshadri S; Delalle I
    J Alzheimers Dis; 2017; 60(1):43-56. PubMed ID: 28777754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.